Zdrowie i gospodarka · 14/12/1998

FDA Amends Regulations for Investigational New Drug Applications

The Food and Drug Administration (FDA) is updating its rules for Investigational New Drug Applications (INDs) for human medications and biological products, requiring a written response within 30 days if a sponsor requests the removal of a clinical hold.